What changed
$MPWR — AVOID 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $804M | EPS $5.10 vs $4.90 🟢 | Margin 30.0%
💡 The market expects continued hyper-growth and multiple expansion; reality is a 4% EPS beat and a fully valued stock with P/E 2.9x its own 3-year median and well above all peer comparables. Variant view: mean reversion in valuation is overdue.
📉 Reward/risk: 0.7:1
🏢 Business Quality: 7/10
📊 Valuation: rich — P/E 113.1x vs historical median 39.3x, peer band 7.3–18.1–46.6x; FCF yield ~2.5%; reverse DCF implies only 4% FCF growth on a $70B market cap...
🔮 Catalyst: Q1'26 earnings beat (already occurred)
💰 Entry: $1417.94, stop $221.43, target $549.03
⚖️ Avoid MPWR for a 3-month long: 113x P/E at 202nd percentile against peer high 47x, with no upcoming catalyst; reward/risk 0.7:1 falls below 2:1 threshold.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/MPWR0624